In a groundbreaking first, psilocybin is entering gastroenterology. Dr. Erin Mauney leads a pioneering study exploring how psychedelic therapy could transform treatment for millions suffering from treatment-resistant Irritable Bowel Syndrome, offering new hope for gut-brain disorders.
Professor Ian N Bruce MD FRCP, Professor of Rheumatology at the University of Manchester shares his expertise here on Systemic Lupus Erythematosus (SLE), a chronic multisystem autoimmune condition.
GreenLight Pharmaceuticals Ltd is advancing clinical research and education in UK and Ireland; Though government progress on access and prescribing recommendations lags behind much of Europe.
MediConnect is pleased to announce that it has received indicative support from the Ugandan government to explore the use of its solution to tackle the spread of counterfeit drugs.
The NHS will test the world's first ‘subscription’ style payment model to incentivise pharmaceutical companies to develop new drugs for resistant infections.
Here, Gerry Morrow discusses whether we will ever see AI fully replicate autonomous decision making and what the future role of AI in diagnostic medicine is.
Dr Takashi Nakamura from Hokkaido University challenges the potential of nano-tech based drug delivery system (Nano DDS) in the development of next-generation cancer immunotherapy.
The UK must address the increasing number of science skills shortages to maintain its world-leading position for medicines and vaccines research and development, says the Association of the British Pharmaceutical Industry (ABPI).
Research reveals that 70% of young men with anxiety report that their work performance and relationships are affected, yet well over half of them are still not seeking help.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group explains cutting-edge technology synergy in the personalised nanomedicine space, with a special focus on pharmaceutical nanomanufacturing
Open Access Government explores the exciting world of chemistry in the UK today, including heterocycles in pharmaceuticals and the importance of inspiring the next generation to work in the field
Marcin Rodzinka, Project Coordinator at Mental Health Europe explains how transparency between the pharma industry and health professionals can influence the quality of mental health care in Europe today
Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University provides an overview of the professional development courses offered at the unit
Life Sciences sector responds to the Business, Energy and Industrial Strategy (BEIS) Committee report on the impact of Brexit on the pharmaceutical sector
